P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT

B. E. Wahlin, J. Brody, T. Phillips, R. Costello, P. Lugtenburg, R. Cordoba, L. Wang, J. Wu, B. Elliott, A. Abbas, J. Jørgensen

Open source

DOI: 10.1097/01.hs9.0000847716.29326.a8
Published: 6
Container: HemaSphere
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/01.hs9.0000847716.29326.a8,
  title = {P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT},
  author = {B. E. Wahlin and J. Brody and T. Phillips and R. Costello and P. Lugtenburg and R. Cordoba and L. Wang and J. Wu and B. Elliott and A. Abbas and J. Jørgensen},
  year = {2022},
  journal = {HemaSphere},
  doi = {10.1097/01.hs9.0000847716.29326.a8},
  url = {https://doi.org/10.1097/01.hs9.0000847716.29326.a8}
}

RIS

TY  - JOUR
TI  - P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT
AU  - B. E. Wahlin
AU  - J. Brody
AU  - T. Phillips
AU  - R. Costello
AU  - P. Lugtenburg
AU  - R. Cordoba
AU  - L. Wang
AU  - J. Wu
AU  - B. Elliott
AU  - A. Abbas
AU  - J. Jørgensen
PY  - 2022
JO  - HemaSphere
DO  - 10.1097/01.hs9.0000847716.29326.a8
UR  - https://doi.org/10.1097/01.hs9.0000847716.29326.a8
ER  -

APA

Wahlin, B. E., Brody, J., Phillips, T., Costello, R., Lugtenburg, P., Cordoba, R., Wang, L., Wu, J., Elliott, B., Abbas, A., & Jørgensen, J. (2022). P1213: SUBCUTANEOUS EPCORITAMAB WITH GEMOX INDUCED HIGH RESPONSE RATES IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA INELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT. HemaSphere. https://doi.org/10.1097/01.hs9.0000847716.29326.a8

Source records

doaj · retrieved 2026-09-27T05:44:06.199Z